@misc{grohmann_biotransformation_of_2017, 
author={Grohmann, L.,Becker, D.,Rademann, J.,Ma, N.,Schaefer-Korting, M.,Weindl, G.},
title={Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues},
year={2017},
howpublished = {journal article},
doi = {https://doi.org/10.1007/s00204-017-1954-5},
abstract = {Reconstructed human epidermis (RHE) is used for risk assessment of chemicals and cosmetics and RHE as well as reconstructed human full-thickness skin (RHS) become important for e.g., the pre-clinical development of drugs. Yet, the knowledge regarding their biotransformation capacity is still limited, although the metabolic activity is highly relevant for skin sensitization, genotoxicity, and the efficacy of topical dermatics. The biotransformation of the aromatic amine 2,4-toluenediamine (2,4-TDA) has been compared in two commercially available RHS to normal human skin ex vivo, and in primary epidermal keratinocytes and dermal fibroblasts as well as in vitro generated epidermal Langerhans cells and dermal dendritic cells. The mono N-acetylated derivative N-(3-amino-4-methyl-phenyl)acetamide (M1) was the only metabolite detectable in substantial amounts indicating the predominance of N-acetylation. RHS exceeded human skin ex vivo in N-acetyltransferase activity and in cell cultures metabolite formation ranked as follows: keratinocytes > fibroblasts ~ Langerhans cells ~ dendritic cells. In conclusion, our results underline the principal suitability of RHS as an adequate test matrix for the investigation of N-acetylation of xenobiotics which is most relevant for risk assessment associated with cutaneous exposure to aromatic amines.},
note = {Online available at: \url{https://doi.org/10.1007/s00204-017-1954-5} (DOI). Grohmann, L.; Becker, D.; Rademann, J.; Ma, N.; Schaefer-Korting, M.; Weindl, G.: Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues. Archives of Toxicology. 2017. vol. 91, no. 10, 3307-3316. DOI: 10.1007/s00204-017-1954-5}}